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Abstract: Dilated cardiomyopathy is the most common type of heart muscle disease in children with idiopathic 
etiology in the majority of cases.  Idiopathic dilated cardiomyopathy (IDCM) is a severe illness   which carries 
a high mortality rate in the pediatric population.  In order to characterize IDCM evolution and identify 
prognostic predictors in our pediatric cardiology center in the western province of Saudi Arabia, 55 patients 
with IDCM were evaluated clinically and by echocardiography. They were followed for a minimum of one year 
and a maximum of four and a half years. Patients less than two years of age represented 69% of the cohort. 
Gender distribution revealed 65.5% female and 35.5% male. Outcomes were divided into four groups: 25 
patients (45.5%) improved (Group I), 17 patients (31%) had a stationary course (Group II), 13 patients 
(23.6%) deteriorated (Group III), and eventually 11 patients (from Group III) died. Survival rate was 80% with 
a mean follow-up period of 36.2 ± 22.1 months.  The older the age at presentation, the worse the prognosis, 
with P value= 0.029. In this study, we found a significant correlation of prognosis with end diastolic volume 
(EDV) (P=0.05) as well as stroke volume (SV) (P=0.04) on presentation. However, fractional shortening of 
ejection fraction on presentation could not be correlated statistically to the prognosis. Also results suggested 
that higher z-score of intraventricular septum & Left ventricular posterior wall dimensions in diastole 
significantly correlated to favorable outcomes and higher z-score of Left ventricular end diastolic dimension 
(LVEDD) was significantly related to unfavorable outcome. We concluded that further multi-center studies are 
necessary to verify predictors of outcome in IDCM patients. Identification of markers affecting early myocardial 
function is essential to achieving improvements in treatments and consequently outcomes in this pediatric 
population. 
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Introduction 
Dilated cardiomyopathy is a heterogeneous 
group of myocardial diseases characterized by 
cardiac dilatation and impaired myocardial 
contractility [1].  DCM is an uncommon disease in 
children but morbidity and mortality in affected 
patients are high [2]. However, a high degree of 
variability has been observed in the clinical course 
and in the morphologic as well as hemodynamic 
features. Despite an intensive search for the cause 
using the most advanced molecular methods, the 
majority of cases (66%) remain designated as 
idiopathic [3-5]. The incidence of cardiomyopathy 
in infants and children is difficult to assess, in part 
because of the variation in diagnostic criteria in 
different regions of the world and partly because of 
the heterogeneous etiologies of the disease [6].  
Arola reported in Finland the annual incidence of 
idiopathic dilated cardiomyopathy (IDCM) in 
children to be 0.34 cases per 100.000 of the age-
specific population [4]. An annual incidence of 1.24 
per 100,000 children younger than age ten for all 
types of cardiomyopathy (dilated, hypertrophic and 
restrictive) was reported in Australia [7]. In a multi-
centre study carried out in the USA, the incidence 
of DCM in children <18 years was 0.57 cases per 
100 000 per year [5]. In DCM, the prognosis is 
often poor irrespective of etiology [8], with a 
reported five-year mortality of up to 80% in IDCM 
patients in some series [4], Studies from 1975-90 
reported 70% survival at two years and 52% 
survival at 11.5 years. Studies from 1992-97 have 
reported up to 85% survival at five years [9-12]. 
DCM is the most common cause for pediatric 
cardiac transplantation in children [13]. Although 
heart transplantation is increasingly used to treat 
this population, selection of patients and timing of 
the procedure remain problematic [4]. Operative 
complications as well as post-operative 
morbidities are considerable; nonetheless 
worldwide availability of such highly specialized 
surgeries is questionable [14]. The clinical course 
of the disease is often unpredictable in the 
individual patient [15] which suggests the need to 
establish an optimal management plan and define 
predictors of prognosis more accurately.  
 
Aim of the Study   
To determine the outcome of children and 
adolescents with idiopathic dilated 
cardiomyopathy (IDCM) and to evaluate 
echocardiographic indicators that may prove 
helpful in predicting prognosis in this patient 
population. 
 
Subject and Methods 
A prospective, clinical observational study was 
planned. All patients presented with the diagnosis 
of idiopathic dilated cardiomyopathy (IDCM) in the 
pediatric cardiology center-Al Noor Specialist 
Hospital (a tertiary care hospital in Makkah-KSA).   
The study was performed over four and a half 
years from June 2001- December 2005. 
Patients included in this study were followed for 
a period of one to four and a half years with a 
mean of 36.2 ± 22.1 months. 
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Inclusion Criteria 
The left ventricular end-diastolic dimension 
(LVEDD) ≥ 2 SD units above normal according to 
the body surface area of the patient,  Ejection 
fraction (EF) was required to be ≤ 50% and 
fractional shortening (FS) had to be   25% [12]. 
 
Exclusion Creteria  
Transient cardiac abnormalities (e.g., acute 
myocarditis), patients were included only if their 
cardiac size or function, or both, remained 
abnormal for at least 6 months. Patients 
diagnosed with secondary forms of myocardial 
disease were also excluded. 
   
There were in total 80 patients diagnosed with 
DCM.  In 25 (roughly 31 %) a cause was found: 
Causes of secondary DCM in these patients were: 
anomalous LCA origin (diagnosed by cardiac 
catheterization), sepsis, severe peri-natal hypoxia, 
post diphtheria, uremia, coarctation and metabolic 
diseases.  
Fifty-five patients had idiopathic dilated 
cardiomyopathy (IDCM). Ages ranged from 1 
month -11 years with a median of 12 ± 37.4 SD 
months.   Females represented 65.5% of the study 
group.   
For all patients our evaluation consisted of the 
following:   
On presentation:  A full history was taken on 
each patient.  Clinical examination  included:   
ECG- Chest X ray - Echocardiography using M 
and 2 D modes, Doppler and color Doppler using 
General Electric medical echocardiographic 
machine (model: vived 7 Pro, GE Vingmed 
ultrasound AS-N190, Horton-Norway equipped 
with 3,7 &12  MHZ transducers).  
 
By echocardiography M-Mode, the following 
measures were taken: Interventricular septum in 
diastole & systole (IVSd & IVSs), Left ventricular 
dimension in diastole& systole (LVEDd & LVEDs), 
Left ventricle posterior wall in diastole & systole 
(LVPd & LVPs). End diastolic volume (EDV), End 
systolic volume (ESV), Stroke volume (SV), 
Fractional shortening (FS) and Ejection fraction 
(EF) were obtained digitally. Z-score of 
echocardiographic measures on presentation was 
calculated [16]. 
 
Therapy 
All patients received diuretics, angiotensin-
converting enzyme (ACE) inhibitors, and digoxin 
with Aspirin (prophylactic dose) as initial therapy. 
Patients were admitted to the hospital for IV 
inotropes if they deteriorated clinically.  Anti-
arrythmic drugs were used if arrhythmias occurred.   
 
Follow-up visits were scheduled at one to 
three month intervals according to patient 
condition and during each visit a full clinical 
examination, ECG, chest X-ray and 
echocardiography were completed. 
 
Grouping 
According to outcomes, patients were divided 
into three groups.  
Group I consisted of patients who improved, 
Group II had a stationary course, and Group III 
were those patients who deteriorated   (both 
clinically and echocardiographically) and/ or died. 
Improvement was defined as an asymptomatic 
situation with left ventricular dimensions and 
function having returned to normal.  Patients with 
a stationary course were asymptomatic or had 
mild symptoms (NYHA I).  This group had either 
persistent left ventricular dilatation and/ or 
dysfunction yet was better than on presentation.  
Patients (or their parents) enrolled in this study 
have responded to an Informed Consent approved 
by the local Ethics Committee on Human 
Research and have found this protocol to be 
acceptable. 
 
Data Analysis 
Continuous data are expressed as median and 
range or mean ± standard deviation (SD) and 
categorical data as frequency percentages. 
Category variable differences were analyzed by 
chi-square analysis. Differences in continuous 
variables by Student’s paired (bilateral) t test 
analyses and multivariate correlation tests were 
used to assess patients’ data before grouping. 
ANOVA test and Student’s paired t test were used 
to assess data after grouping. Probability values ≤ 
0.05 were considered significant. 
 
Results 
In the current study 51% of patients presented 
at age one year or younger, and 69 % presented 
younger than age two, as shown in figure (1). 
In the current study of idiopathic DCM, 49 % of 
patients weighed below the third percentile and 18 
% had a positive family history of cardiac disease.  
Cardiomegaly was noted on chest radiography in 
90% of our patients, but only 56.3 % had 
increased lung vascularity.  ST segment and T 
wave changes were seen on electrocardiogram in 
69% of our cases (38 pts). 69% (38 pts) had LVH, 
13% (7 pts) had low voltage, and 14.5% had 
arrhythmias 
By comparing echocardiography data for 
patients on presentation and at last follow-up 
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using paired T-test, we found a highly significant 
difference in several areas.  These include 
inter-ventricular septum dimension in systole, left 
ventricular systolic dimension, left ventricular 
posterior wall dimension in systole, end systolic 
volume, fractional shortening, & ejection fraction, 
indicating the importance of  these indices as 
valuable indicators for follow-up in this group of 
patients and as predictors of improvement (shown 
in table 1) 
 
 Figure 1: Age of presentaion percentage
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Table 1: presents the absolute echocardiography 
measurements on presentation and follow up 
Significance  Echo  On presentation  Last follow-up 
T-test  P value 
IVSd 5.2±1.1  mm 6.7±6.2 mm  -1.89  0.067 
IVSs 5.9±1.2mm 8.2±6.2  mm  -2.79  0.007 
EDd  44.4± 12.5 mm  43.1±11.8 mm  1.33  0.190 
EDs  37.5± 12.6 mm  33.4±12 mm  2.89  0.006 
VPd  5.52 ± 1.16 mm  5.4± 1.44mm  0.612  0.543 
VPs 6.6±1.5mm  8.97± 6.61mm  -2.57  0.013 
EDV  96.4±44.9 ml  88.72± 57.7ml  1.11  0.273 
ESV 68.1±35.1ml  53.4±  47.4ml  2.68  0.003 
SV 27.7±13.8ml  35.4±  16.7ml  -3.12  0.003 
FS  13.8±5.6 %  23.3 ± 9.5%  -7.53  0.000 
EF  29.4±9.98 %  47.1± 17.3%  -7.47  0.000 
IVSd: Interventricular septum in diastole   IVSs: 
Interventricular septum in systole    LVEDd: Left 
ventricular dimension in diastole   LVEDs: Left ventricular 
dimension in systole  LVPd: Left ventricle posterior wall in 
diastole   LVPs: Left ventricle posterior wall in systole     
ESV: End systolic volume    EDV: End diastolic volume 
SV: Stroke volume  FS: Fractional shortening   EF: 
Ejection fraction Data presented as: mean ± standard 
deviation. 
 
By grouping patients according to outcomes as 
presented in figure 2: 25 patients (45.5%) 
improved (group I), 17 patients (30.9%) had a 
stationary course (group II) and 13 patients (23.6) 
(group III) deteriorated, and eventually 11 died 
(20%). Survival rate over a mean follow-up period 
of about 3 years (36.2 ± 22.1 months) was 80%. 
Prognosis tends to be worse the older the age of 
first presentation but this tendency did not reach 
statistical significance (P=0.053) by t-test.   
However, by ANOVA testing of age in the three 
groups, the relationship was significant with P 
value= 0.029 as shown in table 2. 
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Figure 2: Outcome of patients with idiopatic 
dilated cardiomyopathy
 
 
Table2: The mean age in the three outcome groups and 
their significance. 
Significance 
(ANOVA)   
Group I 
improved 
Group II 
stationary 
Group III 
deteriorated 
F change  P value 
Mean 
age ± 
SD 
26.7± 
28.2 
months 
19.7± 
29.9 
months 
54.2± 
52.2 
months 
3.81 0.029 
 
In the current study, prognosis was correlated 
significantly with end diastolic volume (P=0.05) as 
well as the stroke volume (P = 0.04) but not with 
SF or EF on presentation as measured by all 
statistical tests.  
Since there was a wide range for both the 
patients’ group age & consequently basal surface 
area (BSA), we calculated the z-score of 
echocardiographic measures on presentation.   
Then an inter-groups correlation was performed.   
This revealed the z-score of interventricular 
septum dimension in diastole (IVSd) and 
ventricular posterior wall dimension in diastole 
(LVPd) were significantly higher in the improved 
group (group I) when compared to the other 
groups (group II was stationary & group III 
deteriorated).  There was a p-value 0.01 & 0.007 
respectively.  Left ventricular end diastolic 
dimension (LVEDd) was significantly higher in the 
group that deteriorated (group III) with a P value 
0.004, and  Left ventricular end systolic dimension 
(LVEDs)  tended to be higher as well,  yet did not 
show a significant difference between groups (p 
value 0.122) as illustrated in figure (3). 
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Figure 3: Z-score of the Echocardiographic measures 
on presentation of the three prognosis groups
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Discussion 
Dilated cardiomyopathy (DCM) is one of the 
most common causes of heart failure among 
children and is often progressive despite maximal 
medical therapy [17]. DCM constitutes the 
principal indication for pediatric cardiac 
transplantation [18]. Although the outcomes of 
cardiac transplantation among children are 
improving steadily, there is a paucity of donor 
organs and an increasing number of patients being 
listed, as well as persistent concerns regarding 
intermediate and long-term morbidity and death 
[17]. The epidemiology and clinical course of DCM 
in children are not well established and most 
children have an undiagnosed cause of DCM, 
which limits the potential for disease-specific 
therapies [5].   
Regarding age of presentation:  half of our study 
group patients presented younger than age one 
and about 70% presented before their second 
birthday which is consistent with most published 
data. In a nationwide Finnish study carried out by 
Arola, et al, it was found that 52% of IDCM occurs 
in the first year of life [4]. Also, Towbin, et al, 
reported a higher incidence in infants (<1 year) 
than in children (4.40 vs. 0.34 cases per 100 000; 
P<.001) [5].  Similarly Venugopalan stated that 
studies suggest 50% of patients with new onset 
IDCM are younger than age two [12].  Some 
investigators reported a median age at diagnosis 
of 13 months which is very close to our patients’ 
median age:  12 months [4]. Similarly, in a Turkish 
study, they reported median age at diagnosis to be 
14 months [12]. 
Regarding sex of patients: In the USA, the 
annual incidence is higher in boys than girls (0.66 
vs. 0.47 cases per 100 000; P<.001) [5].  In our 
study, 65.5% of patients were female, whereas in 
the Finnish study 52% were male, and there was a 
male preponderance in most published studies as 
well [7 & 19]. Others have reported no sex 
predilection exists [12]. These differences may be 
attributable to racial basis.  
Regarding family history: Ten patients (18 %) in 
our study group had familial cardiomyopathy. 
Similarly, Michels, et al, in a prospective study 
demonstrated a prevalence of familial disease in 
20% of index cases [20]. Also, other studies have 
shown that genetic causes account for more than 
30% of DCM [21]. 
The measure of improvement: over time 
improvement of IVSs, LVEDs, LVPs, ESV, SV, EF 
& FS has been observed in our patients (before 
grouping) over the follow-up period. This was not 
observed regarding left ventricular diastolic 
dimension. Similarly, other investigators found that 
the overall time interaction was observed and a 
significant difference could be seen within the first 
6 months after diagnosis in the case of LVEDs 
and FS, whereas this was not observed when 
LVEDd was analyzed [4].  
Regarding the outcome: of the current study 
group: about half of our patients improved, which 
is similar to recently published results which 
showed 52.5% of patients recovered [12].  In other 
studies, it has been reported that after a median 
follow-up period of 2.5 years, about one- third of 
patients fully recovered, 38% survived with left 
ventricular dysfunction, and 29.4% died, most in 
the first year of follow-up [22]. This was similar to 
our results that most deaths occurred in the first 
year of follow-up. Similarly, other researchers 
have stated that 33% of DCM cases improve with 
signs of improvement seen in the initial six months 
and continued improvement over two years [23]. 
However, Arola, et al, reported one-, three-, and 
five-year survival rates of 65%, 56%, and 51%, 
respectively [4]. This may be explained by other 
studies which showed that hospital mortality has 
been significantly reduced with the use of 
mechanical assistance and early listing for 
transplantation [24]. 
Our total survival rate was 80% with a mean of 
about 3 years follow up.  Similarly, other authors 
have reported a 16% mortality in DCM children 
awaiting transplantation [8].  Also Burch, et al, 
reported 79% survival rates at one year and 61% 
survival rates at five years [25].  
In general, scientists have stated that 
approximately one third of patients die from the 
disease, one third of patients continue to have 
chronic heart failure requiring therapy, and one 
third of patients experience improvement [12].  
Predictors of outcome: In our study group, 
younger age at presentation was a predictor of 
favorable outcomes in children with idiopathic 
dilated cardiomyopathy.  This is similar to results 
obtained by other researchers who stated that 
good outcome is related to age less than two 
years at presentation [15]. Also recent reports 
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stated that older age at diagnosis was a risk factor 
for subsequent death or transplantation [5]. And 
Burch, et al, reported that age at presentation 
greater than two years was a predictor of adverse 
outcomes [25]. 
In the current study prognosis was correlated 
significantly with end diastolic volume as well as 
the stroke volume & not with SF or EF on 
presentation by all statistical tests. Similar to our 
results, some researchers have stated that there 
were no significant differences between survivor 
and non-survivor DCM patients regarding 
echocardiographic left ventricular end diastolic 
dimension, shortening fraction & left ventricular 
ejection fraction [26].  However, Towbin, et al, 
stated that lower left ventricular fractional 
shortening Z score was risk factor for subsequent 
death or transplantation [5].  Others have stated 
that unfavorable prognosis was more frequently 
associated with lower mean FS [27] which is 
different from our results but they used 
Metaiodobenzylguanidine (MIBG) scintigraphy 
imaging rather than echocardiographic 
measurements. 
The higher z-score result of IVS & LVP in 
diastole was significantly related to favorable 
outcomes. Similarly, previous research proved that 
a relatively thicker posterior wall (with a ratio to the 
cavity dimension > 0.17) was associated with 
better prognosis [28].  Also, we found that higher 
z-score of LVEDd was significantly related to 
unfavorable outcome which is similar to Arola, who 
stated that a more favorable outcome was 
constantly seen in patients with LVEDD   2 SD 
units [4]. 
 
Conclusion 
Our results suggested that in children with 
idiopathic dilated cardiomyopathy: younger age of 
presentation, higher z-score of inter-ventricular 
septum and left ventricle posterior wall dimension 
in diastole are predictors for favorable outcomes,  
and left ventricular end diastolic dimension of high 
z-score is related to unfavorable outcomes. It is 
imperative to develop novel strategies for 
optimizing new methods for early diagnosis and 
risk stratification, as well as new therapies for 
infants and children with dilated cardiomyopathy to 
avoid transplantation and premature death. 
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